ABOUT US
What We Do
Discovery Chemistry
One of the largest and most experienced chemistry discovery organizations having designed and synthesized millions of molecules for hundreds of global organizations
Biology and Pharmacology
Serving key bio-therapeutic areas, including oncology, cell biology, immunology, inflammation, and neuroscience, and providing assays and disease models to drive discovery
DMPK and Exploratory Tox
A science-based culture executing DMPK and tox studies and integrating quality data into drug discovery programs and supporting regulatory filings worldwide
Discovery Biologics
A comprehensive offering for monoclonal antibodies and recombinant proteins from conceptual design to IND filing: discover, engineer, express, purify, and analyze
Biologics CMC/CDMO
Experts at seamlessly transitioning biologics from discovery to CMC development and onto manufacturing to meet mAb production demands for clinical and commercial launch
Dedicated to Scientific Excellence
We are ChemPartner, a life science CRO/CDMO and experts in innovative pharmaceutical research with a global reach.
Our mission is to provide the biopharmaceutical industry with the highest quality R&D services in a timely and cost-effective manner.
Connect With Us
Join us on social media, see our latest news and publications, find us at an upcoming event, or access our large catalog of scientific resources.
LATEST NEWS
Latest News
The 3rd Frontier Forum：New Therapeutics Discovery & Development
2016 Nov. 11th, Nanchang city, Jiangxi province, China The third Frontier Forum of New Therapeutics Discovery & Development was held successfully in Nanchang city, Jiangxi province, China. This is a serial forum hosted and organized by ShangPharma. The themes this...
ChemPartner and Trianni Announce Partnering Agreement
SAN FRANCISCO, Aug. 2, 2016 /PRNewswire/ — Trianni, Inc. (“TRIANNI”) and ChemPartner, a leading science-driven, technologically advanced, high-quality preclinical research partner, today announced an agreement designed to facilitate third-party access to The Trianni...
ShangPharma Congratulates Morphic Therapeutic
July 1, 2016 – SHANGHAI – ShangPharma , a leading China-based pharmaceutical and biotechnology research and development platform company serving healthcare industry, congratulates Morphic Therapeutic for accomplishing $51.5 Million Series A financing to develop...
Headquarters
1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203
Contact Us
China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000